DINGFU BIOTARGET CO., LTD.
9Patents
9Active
9Granted
41Portfolio score
Filing activity: Sep 22, 2015 → Aug 21, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11529425B2 | Immunoconjugates comprising signal regulatory protein alpha | Chemistry; Metallurgy | 3 | Active |
| US11357826B2 | IL-10 EGFR antibody fusion protein and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US10471124B2 | Proteinaceous heterodimer and use thereof | Chemistry; Metallurgy | 1 | Active |
| US10875926B2 | Fully human antibody against human CD 137 | Chemistry; Metallurgy | 1 | Active |
| US11845806B2 | Proteinaceous heterodimer and use thereof | Chemistry; Metallurgy | 1 | Active |
| US11795230B2 | Anti-CD27 antibodies and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11883503B2 | Methods and compositions for cancer treatment | Chemistry; Metallurgy | 0 | Active |
| US10624974B2 | Anti-OX40 antibody and application thereof | Chemistry; Metallurgy | 0 | Active |
| US11987609B2 | Proteinaceous heterodimer and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.